KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) EBT (2016 - 2025)

Astrana Health's EBT history spans 16 years, with the latest figure at $5.7 million for Q3 2025.

  • For Q3 2025, EBT fell 78.85% year-over-year to $5.7 million; the TTM value through Sep 2025 reached $30.2 million, down 63.89%, while the annual FY2024 figure was $80.8 million, 10.04% down from the prior year.
  • EBT for Q3 2025 was $5.7 million at Astrana Health, down from $16.8 million in the prior quarter.
  • Across five years, EBT topped out at $84.4 million in Q2 2021 and bottomed at -$22.4 million in Q4 2021.
  • The 5-year median for EBT is $18.3 million (2022), against an average of $19.3 million.
  • The largest annual shift saw EBT skyrocketed 849.55% in 2022 before it tumbled 305.09% in 2024.
  • A 5-year view of EBT shows it stood at -$22.4 million in 2021, then surged by 146.61% to $10.5 million in 2022, then plummeted by 91.16% to $924000.0 in 2023, then plummeted by 305.09% to -$1.9 million in 2024, then soared by 399.31% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's EBT are $5.7 million (Q3 2025), $16.8 million (Q2 2025), and $9.6 million (Q1 2025).